Develops and supplies commercial seed with advanced traits for farmers, and sells crop-protection products that protect crops from weeds, insects and disease.
10-K for FY2025, filed Feb 12, 2026
Farmers, distributors and manufacturers buy products, with payment generally due within a year of invoicing. Corteva also earns sales-based royalties from intellectual-property licenses.
10-K for FY2025, filed Feb 12, 2026Substantially all of Corteva's revenue is derived from product sales, which consist of sales of Corteva's products to farmers…View ↗
Revenue from product sales is recognized when the customer obtains control of the company's product, which occurs at a point in time…View ↗
Corteva enters into licensing arrangements with customers to license its intellectual property. Revenue from the majority of intellectual…View ↗
10-K for FY2025, filed Feb 12, 2026
FY2025 revenue by reportable segment ↗$17.4B
10-K for FY2025, filed Feb 12, 2026
$17.4B ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Seed
|
57%
FY2022: 51%
|
Seed, FY2025
$9.9B Sources
|
|
|
Crop Protection
Sold outright
10-K for FY2025, filed Feb 12, 2026 |
43%
FY2022: 49%
|
Crop Protection, FY2025
$7.5B Sources
|
Sold outright |
Farmers buy seed directly through independent representatives, while regional and retail channels reach farmers through dealers, distributors and cooperatives. Product sales also go to manufacturers.
Yes. It kept 6 cents of every revenue dollar as net income in FY2025 and turned 16 cents into free cash flow.
10-K for FY2025, filed Feb 12, 2026
$3.3BView ↗
10-K for FY2025, filed Feb 12, 2026
$1.1BView ↗
10-K for FY2025, filed Feb 12, 2026
$2.8BView ↗
10-Q for Q2 FY2026, filed Jul 31, 2026
Open tableView ↗
8-K, filed Jul 30, 2026
1 News Release Corteva Delivers Strong 1H 2026, Raises FY 2026 Outlook, On-Track for October 1 Separation • Seed 1H results reflect…View ↗
8-K, filed Apr 14, 2026
On April 10, 2026, the Company’s board of directors appointed Luther (“Luke”) Kissam, age 61, the Chief Executive Officer of New Corteva…View ↗
Growing. Revenue grew 11% in 4 years, from $15.7B in FY2021 to $17.4B in FY2025, about 3% a year.
Soybean trait portfolio
The older report described an ongoing rollout of Enlist soybean traits and planned reductions in other herbicide-tolerance traits; the latest says substantially all branded soybean offerings carry Enlist traits in Corteva germplasm and describes licensing Conkesta technology in Brazil.
10-K for FY2022, filed Feb 9, 2023 10-K for FY2025, filed Feb 12, 2026In connection with the validation of breeding plans and large-scale product development timelines focused on rapidly ramping up…View ↗
In connection with the validation of breeding plans and large-scale product development timelines focused on rapidly ramping up…View ↗
Competes with BASF, Bayer, FMC, Syngenta, and ChemChina
10-K for FY2025, filed Feb 12, 2026The company competes with producers of seed germplasm, trait developers, and crop protection products on a global basis. The global market…View ↗
Loading...